Drugs News and Research

RSS

New 'Idiopathic Anaphylaxis Yardstick' offers guidance for diagnosis and treatment

Many people in danger of the severe allergic reaction known as anaphylaxis understand exactly what they need to avoid to stay safe.

18 Sep 2019

NUS chemists develop new anti-cancer drug with less renal toxicity

A team of pharmacists and chemists from the National University of Singapore has developed a new anti-cancer drug that has less toxic effects to the kidneys.

18 Sep 2019

Psoriasis drug could be repurposed to treat osteosarcoma

A treatment for psoriasis could be repurposed to treat a rare but aggressive form of youth cancer, new findings from the Garvan Institute of Medical Research suggest.

18 Sep 2019

Compound could play a novel role in halting spread of pancreatic cancer

In early test tube and mouse studies, investigators at Johns Hopkins Medicine and the Johns Hopkins Kimmel Cancer Center have found that nonmuscle myosin IIC (MYH14), a protein activated in response to mechanical stress, helps promote metastatic behavior in pancreatic cancer cells, and that the compound 4-hydroxyacetophenone (4-HAP), known to stiffen myosin IIC-containing cells, can send it into overdrive, overwhelming the ability of cells to invade nearby tissue.

18 Sep 2019

Could drinking a small amount of alcohol everyday be good for type 2 diabetes?

A new meta-analysis suggests that people with type 2 diabetes may benefit from light-to-moderate drinking, which could have a positive effect on blood glucose and fat metabolism.

18 Sep 2019

Genetic mutation appears to help people fight off MRSA

Researchers have discovered that people who carry a certain genetic mutation may have a greater chance of fighting off MRSA infections.

18 Sep 2019

Study looks at outcomes of birth options after a previous cesarean section

A large cohort study of women who have had one or more previous cesarean sections suggests that attempting a vaginal birth in a subsequent pregnancy is associated with higher health risks to both the mother and the infant than electing for another cesarean.

From PLOS ONE 18 Sep 2019

New grant to improve use of bDMARDS through a consortium approach

A new grant to improve the use of biologic disease-modifying anti-rheumatic drugs (bDMARDs) will see NPS MedicineWise and consortium partners support specialist prescribers and help consumers get the most benefit from these complex medicines.

18 Sep 2019

Ground-breaking laser device gets $4.7 million boost from NSF

Deep within the subterranean confines of Building C--the latest addition to the Biodesign Institute at Arizona State University--a pathbreaking machine is quietly taking shape. Designed to unlock some of nature's tiniest and most fleeting mysteries, the Compact X-ray Free Electron Laser (CXFEL) is the only instrument of its kind in the world.

18 Sep 2019

New technology helps trace the origin of Huntington's disease

The first signs of Huntington's, an inherited disease that slowly deteriorates bodies and minds, don't typically surface until middle age.

18 Sep 2019

Brazilian plant extract fights Candidiasis

There are many fungi that live in the body that make up the normal body microbial flora. One type, Candida, a type of yeast, normally thrives in small amounts in areas such as the skin, abdomen, and mouth, without causing any problem. But, when the body’s environment is altered, the yeast can uncontrollably proliferate and cause disease.

17 Sep 2019

Ticks now carrying multiple diseases, says new study

A new study published in the journal mBio reports that ticks carry many more disease-causing agents than just those responsible for causing Lyme disease.

17 Sep 2019

New technique for police to quickly and safely test drug evidence

Scientists have demonstrated a way for police to quickly and safely test whether a baggie or other package contains illegal drugs without having to handle any suspicious contents directly.

17 Sep 2019

New results revealed from pilot stem cell study for stroke

Researchers led by Sean I. Savitz, MD, reported today in the journal Stem Cells that bone marrow cells used to treat ischemic stroke in an expanded Phase I trial were not only safe and feasible, but also resulted in enhanced recovery compared to a matched historical control group.

17 Sep 2019

Familial hypercholesterolemia patients are vulnerable for future heart and stroke events

Individuals with familial hypercholesterolemia (FH) were able to lower their cholesterol under FH specialty care, but many are still not meeting LDL-cholesterol targets, according to the FH Foundation's CASCADE FH® Registry.

17 Sep 2019

Cancer cells survive chemotherapy by eating their neighboring tumor cells

Researchers from the Tulane University School of Medicine have discovered that some cancer cells survive chemotherapy by eating their neighboring tumor cells.

17 Sep 2019

Researchers develop new anti-cancer nanomedicine for targeted chemotherapy

Researchers at the University of Helsinki in collaboration with researchers from Åbo Akademi University, Finland and Huazhong University of Science and Technology, China have developed a new anti-cancer nanomedicine for targeted cancer chemotherapy.

17 Sep 2019

5 million gift will help create Edward P. Evans Center for MDS at Dana-Farber

A $5 million gift from the Edward P. Evans Foundation will create the Edward P. Evans Center for Myelodysplastic Syndromes at Dana-Farber Cancer Institute.

17 Sep 2019

Nanoscale syringe-like bacterial structures could be used to deliver novel drugs

By scraping tubeworms off the bottom of boats in the San Diego harbor to study them, San Diego State University researchers discovered that a beneficial bacterium that aids them in establishing colonies could also be a boon for human health, because the same process might already take place in the human gut.

17 Sep 2019

Pros and cons of gene editing technology

CRISPR technology has greatly facilitated gene editing. Associate Professor Thorsten Müller from Ruhr-Universität Bochum and Dr. Hassan Bukhari from Harvard Medical School discuss its pros and cons in a review article in the journal "Trends in Cell Biology" from 12 September 2019.

17 Sep 2019